6Eknoyan G,Lamrive N,Barsoum R. The burder of kidney disease:Improving global outcome[J].Kidney International,2004,(03):1302-1314.
7National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].American Journal of Kidney Diseases,2002,(2 Suppl 1):S1-S266.
8Garg AX,Kiberd BA,Clark WF. Albuminuria and renal insufficiency prevalence guides population screening:results from the NHANESⅢ[J].Kidney International,2002,(06):2165-2175.doi:10.1046/j.1523-1755.2002.00356.x.
6Ma YC, Zuo L, Chen J H, et al. Modified glomerular filtra- tion rate estimating equation for Chinese patients with chronic kidney disease[J]. J Am Soe Nephrol, 2006,17 (10) :2937-2944.
7National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classifi- cation, and stratification[J]. Am J Kidney Dis, 2002,39 (2 Suppl 1) :S1-266.
8Zhang L,Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lan- cet, 2012,379 (9818) :815-822.
9Zuo L,Ma YC,Zhou YH,et al. Application of GFR-esti- mating equations in Chinese patients with chronic kidney disease[J]. Am J Kidney Dis,2005,45(3) 463-472.
